GLOBAL Research & Medical Care Roundtable at NDSC
Global Down Syndrome Foundation
Thursday, July 20, 2023
NDSC 51st Annual Convention, JW Marriott, Orlando, Florida
Co-Organized with the NDSC, the GLOBAL Roundtable is a free benefit and features internationally renowned scientists and medical professionals. Important topics covered included updates on:
- Pediatric Care
- Adult Care
- Important Clinical Trials
- Regression
- Vision
- Alzheimer’s and more

Bryn Gelaro, MA
Research & Medical Care Senior Director, Global Down Syndrome Foundation
Welcome Remarks
Frank Stephens
Self-Advocate, Actor, Author, Board Member, Global Down Syndrome Foundation
Welcome Remarks
Michelle Sie Whitten, MA
Co-Founder, President & CEO, Global Down Syndrome Foundation
GLOBAL Update & Moderator
Joaquín Espinosa, PhD
Executive Director, Linda Crnic Institute for Down Syndrome; Professor in the Department of Pharmacology at the University of Colorado School of Medicine
Arwen Jackson, MA, CCC-SLP
Speech-Language Pathologist III, Sie Center for Down Syndrome at Children’s Hospital Colorado
Feeding and Swallowing in Children with Down Syndrome; Translating Current Research into Clinical Practice
In this session, Arwen Jackson will provide an overview of the commonly occurring feeding and swallowing concerns present in children with Down syndrome and review the latest research. Specific signs and symptoms of feeding and swallowing difficulties will be discussed, as well as recommendations for intervention and the role of multidisciplinary management.

Brian Chicoine, MD
Adult Down Syndrome Center Faculty, Family Medicine Residency, Advocate Lutheran General Hospital
Forming a Partnership with Your Health Care Provider
In this presentation, Brian Chicoine, MD, will discuss strategies for collaborating with health care providers to improve the health care of adults with Down syndrome. He will discuss best practices for working with individuals with Down syndrome in health care settings and share resources about health and wellness for adults with Down syndrome.

Jonathan Santoro, MD
Director of Neuroimmunology and Demyelinating Disorders Program, Children’s Hospital Los Angeles. Assistant Professor of Neurology, Keck School of Medicine, University of Southern California
Biomarkers of Down Syndrome Regression Disorder: A Window into the Role of Immunotherapy
In this session, Dr. Santoro will review the clinical features of Down Syndrome Regression Disorder, specifically spending time reviewing the role and importance of neurodiagnostic studies such as EEG, MRI and lumbar puncture (spinal tap). He will discuss the role of immunotherapy (specifically IVIg) in the treatment of DSRD and provide details of the upcoming NIH-sponsored clinical trial investigating mechanisms of disease in persons with DSRD.

Melissa Parisi, MD, PhD
Chief, Intellectual and Developmental Disabilities Branch Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD)
